Marketing of unproven stem cell-based interventions: A call to action.
Sipp D., Caulfield T., Kaye J., Barfoot J., Blackburn C., Chan S., De Luca M., Kent A., McCabe C., Munsie M., Sleeboom-Faulkner M., Sugarman J., van Zimmeren E., Zarzeczny A., Rasko JEJ.
Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments.